Australian Statistics on Medicines 2011
Table 1 - Genito Urinary System and Sex Hormones
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G01AA10 |
CLINDAMYCIN |
||||||
A |
15081 |
Vaginal cream 2% 40gm |
0.10 |
GM |
22,102 |
- |
|
G01AA01 |
NYSTATIN |
||||||
P |
4013F |
Vaginal cream 100,000 units per dose, 15 doses, 75g |
100.00 |
TE |
6,805 |
93,827 |
|
ORGANIC ACIDS |
|||||||
G01AD02 |
RICINOLEIC ACID, ACETIC ACID and HYDROXYQUINOLINE SULPHATE |
||||||
P |
4434J |
Vaginal jelly 7mg-9.4mg-250ug per g |
- |
- |
311 |
10,257 |
|
IMIDAZOLE DERIVATIVES |
|||||||
G01AF02 |
CLOTRIMAZOLE |
||||||
A |
15913 |
Pessary 500mg |
0.10 |
GM |
2,364 |
- |
|
A |
19067 |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
394 |
- |
|
A |
20605 |
Pessaries 100mg 6 |
0.10 |
GM |
4,622 |
- |
|
A |
20606 |
Pessary 500mg |
0.10 |
GM |
3,022 |
- |
|
A |
20607 |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
8,137 |
- |
|
A |
20608 |
Vaginal cream 100mg per 5g (2%) 20g |
0.10 |
GM |
7,249 |
- |
|
P |
4016J |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
658 |
9,932 |
|
P |
4017K |
Vaginal cream 100mg per 5g (2%) 20g |
0.10 |
GM |
404 |
6,164 |
|
G01AF20 |
CLOTRIMAZOLE and FLUCONAZOLE |
||||||
A |
20144 |
Vaginal Cream 1% 10g and capsule 150mg 1 |
- |
- |
1,491 |
- |
|
G01AF05 |
ECONAZOLE NITRATE |
||||||
A |
12661 |
Foam-sol 1%10g 3 |
0.10 |
GM |
1,625 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G02BA03 |
LEVONORGESTREL |
||||||
P |
8633J |
Intrauterine drug 52mg releasing 20ug per 24 hours |
- |
- |
89,088 |
21,869,307 |
|
G02BA02 |
POLYETHYLENE COPPER |
||||||
A |
13296 |
Intrauterine device 1 |
- |
- |
1,804 |
- |
|
OTHER GYNAECOLOGICALS |
|||||||
PROLACTIN INHIBITORS |
|||||||
G02CB01 |
BROMOCRIPTINE MESYLATE |
||||||
P |
1444B |
Tablet 2.5mg |
5.00 |
MG |
3,765 |
73,971 |
|
G02CB03 |
CABERGOLINE |
||||||
P |
8114C |
Tablet 0.5mg |
0.50 |
MG |
32,903 |
2,512,297 |
|
P |
8115D |
Tablet 0.5mg |
0.50 |
MG |
2,148 |
69,986 |
|
G02CB04 |
QUINAGOLIDE |
||||||
P |
8822H |
Tablet 75ug (base) |
75.00 |
UG |
846 |
57,928 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G03AA09 |
DESOGESTREL with ETHINYLOESTRADIOL |
||||||
A |
14249 |
Tablet 28 1 150 ug/30ug |
- |
- |
60,128 |
- |
|
G03AA |
DIENOGEST with ETHINYLOESTRADIOL |
||||||
A |
19955 |
Tablet 2mg-30ug + 7 inert 28 |
- |
- |
2,965 |
- |
|
A |
19956 |
Tablet 2mg-30ug + 7 inert 28x3 |
- |
- |
25,183 |
- |
|
A |
21042 |
Tablet 2mg-30ug + 7 inert 28 |
- |
- |
216 |
- |
|
A |
21043 |
Tablet 2mg-30ug + 7 inert 28x3 |
- |
- |
5,145 |
- |
|
G03AA |
ETHINYLOESTRADIOL and ETONOGESTREL |
||||||
A |
19917 |
Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 1 |
- |
- |
12,395 |
- |
|
A |
19918 |
Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 3 |
- |
- |
34,481 |
- |
|
G03AA12 |
ETHINYLOESTRADIOL with DROSPIRENONE |
||||||
A |
17645 |
Tablet 3mg-30ug 21 + 7 inert |
- |
- |
101,506 |
- |
|
A |
17646 |
Tablet 3mg-30ug 21 + 7 inert 28x3 |
- |
- |
463,617 |
- |
|
A |
20451 |
Tablet 3mg-20ug 24+4 |
- |
- |
53,594 |
- |
|
A |
20452 |
Tablet 3mg-20ug 24+4 28x3 |
- |
- |
256,778 |
- |
|
G03AA10 |
ETHINYLOESTRADIOL with GESTODENE |
||||||
A |
15082 |
Tablets 75ug/30ug, 21 + 7 |
- |
- |
123 |
- |
|
G03AA07 |
LEVONORGESTREL with ETHINYLOESTRADIOL |
||||||
P |
1394J |
Tablets 150ug-30ug 21 + 7 inert 28 |
- |
- |
1,560,035 |
26,489,624 |
|
P |
1456P |
Tablets 125ug-50ug 21 + 7 inert |
- |
- |
84,499 |
1,435,511 |
|
A |
16212 |
Tablets 100ug-50ug 28 |
- |
- |
128,351 |
- |
|
A |
16217 |
Tablets 100ug-20ug + 7 inert 28 |
- |
- |
15,837 |
- |
|
A |
16970 |
Tablets 100ug-20ug 21 + 7 inert |
- |
- |
111,383 |
- |
|
A |
17708 |
Tablets 100ug 20ug + 7 inert 28x3 |
- |
- |
9,880 |
- |
|
G03AA05 |
NORETHISTERONE with ETHINYLOESTRADIOL |
||||||
P |
2772X |
Tablets 500ug-35ug 21 |
- |
- |
137 |
2,043 |
|
P |
2773Y |
Tablets 1mg-35ug, 21 |
- |
- |
233 |
2,892 |
|
P |
2774B |
Tablets 500ug-35ug 21 + 7 inert 28 |
- |
- |
114,210 |
1,877,945 |
|
P |
2775C |
Pack containing 21 tablets 1mg-35ug |
- |
- |
90,679 |
1,491,579 |
|
G03AA05 |
NORETHISTERONE with MESTRANOL |
||||||
P |
3176E |
Tablets 1mg-50ug 21 |
- |
- |
1,368 |
22,562 |
|
P |
3179H |
Tablets 1mg-50ug 21 + 7 inert 28 |
- |
- |
14,175 |
233,296 |
|
G03AA12 |
OESTRADIOL with DROSPIRENONE |
||||||
A |
19550 |
Tablet 1mg-2mg 28 |
- |
- |
43,578 |
- |
|
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|||||||
G03AB06 |
ETHINYLOESTRADIOL with GESTODENE |
||||||
A |
18555 |
Tablet 30ug/75ug 28x3 |
- |
- |
19,183 |
- |
|
G03AB03 |
LEVONORGESTREL with ETHINYLOESTRADIOL |
||||||
P |
1392G |
Pack containing 6 tablets 50ug |
- |
- |
360,338 |
6,124,859 |
|
G03AB04 |
NORETHISTERONE with ETHINYLOESTRADIOL |
||||||
A |
21514 |
Norethisterone 0.5mg and ethinlyoestradiol 35 mcg 21 active tablets |
- |
- |
171 |
- |
|
P |
2776D |
Tablets 500/35ug 12,1000/35ug 9 + 7 inert |
- |
- |
4,003 |
65,942 |
|
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
|||||||
PROGESTOGENS |
|||||||
G03AC08 |
ETONOGESTREL |
||||||
P |
8487Q |
Subcutaneous implant 68mg |
0.07 |
MG |
87,744 |
18,920,108 |
|
G03AC06 |
MEDROXYPROGESTERONE |
||||||
P |
3118D |
Injection 150mg in 1mL |
1.67 |
MG |
220,018 |
4,700,987 |
|
G03AC01 |
NORETHISTERONE |
||||||
P |
1967M |
Tablets 350ug 28 |
- |
- |
36,991 |
607,970 |
|
EMERGENCY CONTRACEPTIVES |
|||||||
G03AD01 |
LEVONORGESTREL |
||||||
A |
19549 |
Tablet 0.75mg 2 |
- |
- |
14,649 |
- |
|
A |
20453 |
Tablet 1.5mg 1 |
- |
- |
2,724 |
- |
|
A |
20617 |
Tablet 1.5mg 1 |
- |
- |
16,609 |
- |
|
A |
21159 |
Tablet 1.5mg 1 |
- |
- |
8,175 |
- |
|
P |
2913H |
Tablets 30ug 28 |
0.03 |
MG |
124,534 |
2,149,461 |
|
ANDROGENS |
|||||||
3-OXOANDROSTEN (4) DERIVATIVES |
|||||||
G03BA03 |
TESTOSTERONE |
||||||
A |
16153 |
Cream 2% 50g |
- |
- |
147 |
- |
|
A |
17178 |
Cream 5% 50g |
- |
- |
133 |
- |
|
P |
2101N |
Injection 250mg |
18.00 |
MG |
34,392 |
1,166,156 |
|
P |
2114G |
Injection 250mg in 1mL |
18.00 |
MG |
17,631 |
598,786 |
|
P |
2115H |
Capsule 40mg |
120.00 |
MG |
29,683 |
1,520,481 |
|
A |
21420 |
Injection 100mg in 1mL |
18.00 |
MG |
431 |
- |
|
P |
8098F |
Subcutaneous implant 100mg |
18.00 |
MG |
2,457 |
412,963 |
|
P |
8099G |
Subcutaneous implant 200mg |
18.00 |
MG |
2,089 |
535,722 |
|
P |
8460G |
Transdermal patch 12.2mg (2.5mg per 24 hr) 60 |
3.00 |
MG |
2,841 |
285,083 |
|
P |
8619P |
Transdermal patch 24.3mg (5mg per 24 hr) 30 |
3.00 |
MG |
7,463 |
771,479 |
|
P |
8830R |
Transdermal gel 50mg in 5mg sachet 30 |
50.00 |
MG |
63,758 |
7,011,327 |
|
P |
9004X |
Injection 1000 mg in 4mL |
18.00 |
MG |
55,195 |
8,148,459 |
|
5-ANDROSTANON (3) DERIVATIVES |
|||||||
G03BB01 |
MESTEROLONE |
||||||
A |
11642 |
Tablet 25mg 50 |
50.00 |
MG |
722 |
- |
|
ESTROGENS |
|||||||
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN |
|||||||
G03CA03 |
OESTRADIOL |
||||||
A |
16209 |
Tablet 1mg 28 |
2.00 |
MG |
11,210 |
- |
|
A |
16210 |
Tablet 2mg 28 |
2.00 |
MG |
11,571 |
- |
|
P |
1742Q |
Vaginal tablets 25ug |
0.03 |
MG |
571,857 |
13,280,605 |
|
P |
1743R |
Transdermal patches 2mg 8 |
0.05 |
MG |
55,911 |
961,546 |
|
P |
1745W |
Transdermal patches 8mg 8 |
0.05 |
MG |
17,220 |
331,232 |
|
A |
21759 |
Implant 50mg 1 |
1.00 |
MG |
117 |
- |
|
A |
21760 |
Implant 100mg 1 |
1.00 |
MG |
632 |
- |
|
P |
8125P |
Transdermal patches 3.9mg (releasing 50ug/24hrs) |
0.05 |
MG |
41,923 |
716,562 |
|
ESTROGENS |
|||||||
P |
8126Q |
Transdermal patches 7.8mg (releasing 100ug/24hrs) |
0.05 |
MG |
12,326 |
241,166 |
|
P |
8140K |
Transdermal patches 1.5mg (releasing 50ug/24hrs) |
0.05 |
MG |
36,877 |
630,560 |
|
P |
8286D |
Transdermal gel 1mg in 1g sachet 28 |
1.00 |
MG |
71,454 |
1,270,506 |
|
P |
8311K |
Transdermal pat 750ug (rel 25ug/24 hrs) |
0.05 |
MG |
14,060 |
240,271 |
|
P |
8312L |
Transdermal patch 3mg (rel 100ug/24 hrs) |
0.05 |
MG |
7,012 |
137,278 |
|
P |
8485N |
Transdermal patches 2mg (releasing 25ug/24hrs) |
0.05 |
MG |
21,640 |
369,238 |
|
P |
8486P |
Transdermal patches 5.7mg (releasing 75ug/24hrs) |
0.05 |
MG |
10,421 |
199,853 |
|
P |
8761D |
Transdermal patches 3.9mg (releasing 25ug/24hrs) |
0.05 |
MG |
20,352 |
347,038 |
|
P |
8762E |
Transdermal patches 5.85mg (releasing 37.5ug/24hrs) |
0.05 |
MG |
25,435 |
433,984 |
|
P |
8763F |
Transdermal patches 7.8mg (releasing 500ug/24hrs) |
0.05 |
MG |
71,470 |
1,220,443 |
|
P |
8764G |
Transdermal patches 1.17mg (releasing 75ug/24hrs) |
0.05 |
MG |
25,905 |
495,742 |
|
P |
8765H |
Transdermal patches 1.56mg (releasing 100ug/24hrs) |
0.05 |
MG |
25,944 |
513,256 |
|
G03CA03 |
OESTRADIOL VALERATE |
||||||
P |
1663M |
Tablets 1mg 28 |
2.00 |
MG |
96,040 |
1,120,074 |
|
P |
1664N |
Tablets 2mg 28 |
2.00 |
MG |
99,746 |
1,407,039 |
|
P |
4365R |
Implant 50mg 1 |
- |
- |
310 |
15,040 |
|
P |
4366T |
Implant 100mg 1 |
- |
- |
1,602 |
194,757 |
|
P |
8274L |
Tablets 2mg 56 |
2.00 |
MG |
12,082 |
164,847 |
|
G03CA04 |
OESTRIOL |
||||||
P |
1771F |
Pessaries 500ug 15 |
0.20 |
MG |
18,366 |
390,088 |
|
P |
1781R |
Vaginal cream 1mg per g (0.1%) 15g |
0.20 |
MG |
259,641 |
4,969,938 |
|
A |
19732 |
Tablets 1mg 30 |
2.00 |
MG |
2,697 |
- |
|
G03CA57 |
OESTROGENS CONJUGATED |
||||||
A |
20689 |
Tablets 300ug 28 |
0.63 |
MG |
123,117 |
- |
|
A |
20690 |
Tablets 625ug 28 |
0.63 |
MG |
193,374 |
- |
|
OTHER ESTROGENS |
|||||||
G03CX01 |
TIBOLONE |
||||||
A |
16835 |
Tablet 2.5mg 28 |
2.50 |
MG |
105,645 |
- |
|
A |
20242 |
Tablet 2.5mg 28 |
2.50 |
MG |
144,631 |
- |
|
PROGESTOGENS |
|||||||
PREGNEN (4) DERIVATIVES |
|||||||
G03DA02 |
MEDROXYPROGESTERONE |
||||||
A |
14247 |
Tablet 2.5mg |
5.00 |
MG |
2,443 |
- |
|
P |
2321E |
Tablet 10mg |
5.00 |
MG |
33,027 |
528,928 |
|
P |
2323G |
Tablet 5mg 56 |
5.00 |
MG |
77,600 |
1,139,770 |
|
P |
2722G |
Tablet 10mg |
5.00 |
MG |
16,499 |
514,321 |
|
G03DA04 |
PROGESTERONE |
||||||
A |
18750 |
Pessaries 200mg 15 |
90.00 |
MG |
3,167 |
- |
|
P |
6366C |
Gel Vaginal (prolonged release) 90mg single dose |
90.00 |
MG |
332 |
- |
|
PREGNADIEN DERIVATIVES |
|||||||
G03DB01 |
DYDROGESTERONE |
||||||
P |
1350C |
Tablet 10mg |
10.00 |
MG |
880 |
13,289 |
|
ESTREN DERIVATIVES |
|||||||
PROGESTOGENS |
|||||||
G03DC02 |
NORETHISTERONE |
||||||
P |
2993M |
Tablet 5mg |
5.00 |
MG |
122,856 |
4,601,305 |
|
PROGESTOGENS AND ESTROGENS IN COMBINATION |
|||||||
PROGESTOGENS AND ESTROGENS,FIXED COMBINATIONS |
|||||||
G03FA12 |
MEDROXYPROGESTERONE and ESTROGEN |
||||||
A |
20691 |
Tablet 625ug 2.5mg 28 |
- |
- |
72,403 |
- |
|
A |
20692 |
Tablet 625ug 5mg 28 |
- |
- |
87,737 |
- |
|
G03FA01 |
NORETHISTERONE and ESTROGEN |
||||||
A |
20742 |
Tablets 1mg-500ug, 28 |
- |
- |
117,141 |
- |
|
A |
20743 |
Pack containing 28 tablets 2mg-1mg |
- |
- |
74,358 |
- |
|
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|||||||
G03FB08 |
DYDROGESTERONE and ESTROGEN |
||||||
P |
8244X |
Tabs estradiol 2mg+est/dydro 2mg/10mg,28mg(14/14) |
- |
- |
16,058 |
301,477 |
|
G03FB06 |
MEDROXYPROGESTERONE and ESTROGEN |
||||||
A |
19194 |
Pack 14 tablets oestrogens 625ug |
- |
- |
242 |
- |
|
G03FB05 |
OESTRADIOL with NORETHISTERONE ACETATE |
||||||
A |
20741 |
Tablets sequential pack 2mg-1mg |
- |
- |
52,039 |
- |
|
P |
8425K |
Transdermal patch 4 4.33mg, 4 620ug/2.7mg |
- |
- |
15,294 |
292,633 |
|
P |
8426L |
Transdermal patch 4 4.33mg, 4 510ug/4.8mg |
- |
- |
9,951 |
191,137 |
|
P |
8427M |
Transdermal patch 620ug/2.7mg, 8 50ug/day |
- |
- |
68,297 |
1,304,882 |
|
P |
8428N |
Transdermal patch 510ug/4.8mg, 8 |
- |
- |
27,779 |
530,985 |
|
GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
|||||||
GONADOTROPHINS |
|||||||
G03GA05 |
FOLLITROPIN ALFA |
||||||
P |
8713N |
Injection 300iu in 0.5mL multi-dose cartridge |
75.00 |
IE |
438 |
297,229 |
|
P |
8714P |
Injection 450iu in 0.75mL multi-dose cartridge |
75.00 |
IE |
568 |
424,396 |
|
P |
8715Q |
Injection 900iu in 1.5mL multi-dose cartridge |
75.00 |
IE |
1,673 |
1,713,871 |
|
G03GA06 |
FOLLITROPIN BETA |
||||||
P |
8565T |
Soln for injection 300iu in 0.36mL mulit-dose cart |
75.00 |
IE |
1,336 |
675,034 |
|
P |
8566W |
Soln for injection 600iu in 0.75mL mulit-dose cart |
75.00 |
IE |
1,743 |
1,219,683 |
|
P |
8871X |
Soln for injection 900iu in 1.08mL mulit-dose cart |
75.00 |
IE |
1,269 |
1,172,176 |
|
G03GA01 |
HUMAN CHORIONIC GONADOTROPHIN |
||||||
P |
1581F |
Ampoules pdr for inj. 1500units and 1mL solvent 3/3 |
250.00 |
IE |
3,423 |
281,302 |
|
P |
6181H |
Powder for inj. 5000units with solvent |
250.00 |
IE |
7,988 |
- |
|
OVULATION STIMULANTS, SYNTHETIC |
|||||||
G03GB02 |
CLOMIPHENE CITRATE |
||||||
P |
1211R |
Tablet 50mg |
9.00 |
MG |
41,287 |
1,432,531 |
|
ANTIANDROGENS |
|||||||
ANTIANDROGENS, PLAIN PREPARATIONS |
|||||||
G03HA01 |
CYPROTERONE ACETATE |
||||||
P |
1269T |
Tablet 50mg |
0.10 |
GM |
21,000 |
1,205,473 |
|
P |
1270W |
Tablet 50mg |
0.10 |
GM |
13,087 |
2,434,548 |
|
P |
8019C |
Tablet 100mg |
0.10 |
GM |
30,394 |
5,515,440 |
|
ANTIANDROGENS |
|||||||
ANTIANDROGENS AND ESTROGENS |
|||||||
G03HB01 |
CYPROTERONE and ETHINYLOESTRADIOL |
||||||
A |
20836 |
Tablet 35ug/2mg 28 3 |
- |
- |
206,249 |
- |
|
G03HB01 |
CYPROTERONE and OESTROGEN |
||||||
A |
14126 |
Tablet 35ug/2mg 28 1 |
- |
- |
7,363 |
- |
|
A |
14127 |
Tablet 35ug/2mg 28 3 |
- |
- |
45,675 |
- |
|
A |
15418 |
Tablet 35ug/2mg 28 1 |
- |
- |
6,842 |
- |
|
A |
15419 |
Tablet 35ug/2mg28 3 |
- |
- |
151,095 |
- |
|
A |
17090 |
Tablet 35ug/2mg28 1 |
- |
- |
3,912 |
- |
|
A |
17091 |
Tablet 35ug/2mg28 3 |
- |
- |
67,874 |
- |
|
A |
18070 |
Tablet 35ug/2mg 28 1 |
- |
- |
7,329 |
- |
|
A |
18071 |
Tablet 35ug/2mg 28 3 |
- |
- |
142,842 |
- |
|
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|||||||
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||||
G03XA01 |
DANAZOL |
||||||
P |
1285P |
Capsule 100mg |
0.60 |
GM |
683 |
40,147 |
|
P |
1287R |
Capsule 200mg |
0.60 |
GM |
1,325 |
116,355 |
|
G03XA02 |
GESTRINONE |
||||||
P |
8015W |
Capsule 2.5mg |
0.70 |
MG |
182 |
14,857 |
|
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||||
G03XC01 |
RALOXIFENE |
||||||
P |
8363E |
Tablet 60mg 28 |
60.00 |
MG |
224,491 |
12,981,751 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G04BD10 |
DARIFENACIN |
||||||
A |
19785 |
Tablet modified release 7.5 mg (H B r salt) 28 |
7.50 |
MG |
3,930 |
- |
|
A |
19786 |
Tablet modified release 15mg (H B r salt) 28 |
7.50 |
MG |
4,567 |
- |
|
G04BD04 |
OXYBUTYNIN |
||||||
P |
8039D |
Tablet 5mg |
15.00 |
MG |
255,511 |
3,920,696 |
|
P |
9454N |
Transdermal patches 36mg (releasing approx. 3.9mg per 24 hrs) 8, 1 |
3.90 |
MG |
74,079 |
2,615,181 |
|
G04BD08 |
SOLIFENACIN |
||||||
A |
19781 |
Tablet 5mg 30 |
5.00 |
MG |
86,792 |
- |
|
A |
19782 |
Tablet 10mg 30 |
5.00 |
MG |
50,884 |
- |
|
G04BD07 |
TOLTERODINE |
||||||
A |
18891 |
Tablet 1mg 56 |
4.00 |
MG |
2,153 |
- |
|
A |
18892 |
Tablet 2mg 56 |
4.00 |
MG |
8,828 |
- |
|
DRUGS USED IN ERECTILE DYSFUNCTION |
|||||||
G04BE01 |
ALPROSTADIL |
||||||
P |
4579B |
Intracavernosal injection 10ug in single syringe |
0.02 |
MG |
8,952 |
736,074 |
|
P |
4580C |
Intracavernosal injection 20 ug in single syringe |
0.02 |
MG |
16,761 |
1,747,377 |
|
G04BE03 |
SILDENAFIL |
||||||
A |
20993 |
Tablet 100mg 12 |
50.00 |
MG |
4,000 |
- |
|
P |
4584G |
Tablet 25mg 4 |
50.00 |
MG |
4,044 |
712,492 |
|
P |
4585H |
Tablet 50mg 4 |
50.00 |
MG |
39,292 |
3,272,608 |
|
P |
4586J |
Tablet 100mg 4 |
50.00 |
MG |
323,114 |
26,162,306 |
|
P |
9605M |
Tablet 20mg 90 |
50.00 |
MG |
1,173 |
1,109,415 |
|
G04BE08 |
TADALAFIL |
||||||
A |
18863 |
Tablet 20mg 8 |
10.00 |
MG |
65,963 |
- |
|
A |
20367 |
Tablet 5mg 28 |
10.00 |
MG |
29,623 |
- |
|
P |
4596X |
Tablet 10mg 4 |
10.00 |
MG |
17,019 |
1,355,515 |
|
P |
4597Y |
Tablet 20mg 4 |
10.00 |
MG |
231,454 |
19,261,955 |
|
G04BE09 |
VARDENAFIL |
||||||
A |
17959 |
Tablet 5mg 4 |
10.00 |
MG |
257 |
- |
|
A |
17961 |
Tablet 10mg 4 |
10.00 |
MG |
2,304 |
- |
|
A |
17962 |
Tablet 20mg 2 |
10.00 |
MG |
114 |
- |
|
A |
17963 |
Tablet 20mg 2 |
10.00 |
MG |
35,381 |
- |
|
A |
20239 |
Tablet 20mg 8 |
10.00 |
MG |
12,256 |
- |
|
OTHER UROLOGICALS |
|||||||
G04BX |
SODIUM BICARBONATE |
||||||
P |
9470K |
Capsule 840mg 100 |
- |
- |
45,743 |
650,142 |
|
G04BX |
SODIUM CITRO-TARTRATE |
||||||
P |
4049D |
Sachets cont. oral effervescent powder 4g 28 |
- |
- |
26,070 |
358,811 |
|
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
|||||||
ALPHA-ADRENORECEPTOR ANTAGONISTS |
|||||||
G04CA01 |
ALFUZOSIN |
||||||
A |
20995 |
Tablet 10mg 30 |
7.50 |
MG |
5,172 |
- |
|
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
|||||||
A |
20996 |
Tablet 10mg 60 |
7.50 |
MG |
489 |
- |
|
G04CA02 |
TAMSULOSIN |
||||||
P |
4070F |
Tablet 400ug (prolonged release) 30 |
0.40 |
MG |
328,518 |
20,815,466 |
|
G04CA52 |
TAMSULOSIN and DUTASTERIDE |
||||||
A |
21496 |
Capsule containing dutasteride 500ug with tamsulosin hydrochloride 400ug 30 |
- |
- |
122 |
- |
|
P |
5490Y |
Capsule containing dutasteride 500ug with tamsulosin hydrochloride 400ug 30 |
- |
- |
35,544 |
1,241,396 |
|
G04CA03 |
TERAZOSIN |
||||||
P |
4397K |
Tablet 2mg |
5.00 |
MG |
2,115 |
99,676 |
|
P |
4398L |
Tablet 5mg |
5.00 |
MG |
1,633 |
105,120 |
|
P |
4399M |
Tablet 10mg |
5.00 |
MG |
1,286 |
110,559 |
|
TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS |
|||||||
G04CB02 |
DUTASTERIDE |
||||||
P |
5468T |
Capsule 500ug 30 |
0.50 |
MG |
42,910 |
1,258,078 |
|
G04CB01 |
FINASTERIDE |
||||||
A |
16113 |
Tablet 1mg 28 |
- |
- |
64,578 |
- |
|
A |
20715 |
Tablet 5mg 30 |
5.00 |
MG |
6,285 |
- |
|
A |
21366 |
Tablet 5mg 30 |
5.00 |
MG |
197 |
- |
|
A |
21407 |
Tablet 5mg 30 |
5.00 |
MG |
416 |
- |
|
P |
4233T |
Tablet 5mg |
5.00 |
MG |
59,899 |
6,529,916 |